In addition to Radboudumc, KNCV Tuberculosis Foundation from the Netherlands also participates in UNITE4TB, which is supported on an organizational level by the Dutch non-profit organization Lygature. The participants also include a range of top European universities, including the London School for Hygiene and Tropical Medicine, institutions from the United States and South Africa and, among others, the globally active pharmaceutical companies GSK and Janssen.
–
